AKTX
Price
$0.28
Change
+$0.01 (+3.70%)
Updated
Jan 15, 11:05 AM (EDT)
Capitalization
9.8M
Intraday BUY SELL Signals
CVKD
Price
$8.29
Change
-$0.11 (-1.31%)
Updated
Jan 15, 11:16 AM (EDT)
Capitalization
19.64M
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AKTX vs CVKD

Header iconAKTX vs CVKD Comparison
Open Charts AKTX vs CVKDBanner chart's image
Akari Therapeutics
Price$0.28
Change+$0.01 (+3.70%)
Volume$182
Capitalization9.8M
Cadrenal Therapeutics
Price$8.29
Change-$0.11 (-1.31%)
Volume$200
Capitalization19.64M
AKTX vs CVKD Comparison Chart in %
AKTX
Daily Signal:
Gain/Loss:
CVKD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AKTX vs. CVKD commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTX is a Hold and CVKD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AKTX: $0.27 vs. CVKD: $8.40)
Brand notoriety: AKTX and CVKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKTX: 18% vs. CVKD: 80%
Market capitalization -- AKTX: $9.8M vs. CVKD: $19.64M
AKTX [@Biotechnology] is valued at $9.8M. CVKD’s [@Biotechnology] market capitalization is $19.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKTX’s FA Score shows that 1 FA rating(s) are green whileCVKD’s FA Score has 0 green FA rating(s).

  • AKTX’s FA Score: 1 green, 4 red.
  • CVKD’s FA Score: 0 green, 5 red.
According to our system of comparison, both AKTX and CVKD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKTX’s TA Score shows that 5 TA indicator(s) are bullish while CVKD’s TA Score has 3 bullish TA indicator(s).

  • AKTX’s TA Score: 5 bullish, 3 bearish.
  • CVKD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AKTX is a better buy in the short-term than CVKD.

Price Growth

AKTX (@Biotechnology) experienced а -6.92% price change this week, while CVKD (@Biotechnology) price change was +12.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

CVKD is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVKD($19.6M) has a higher market cap than AKTX($9.8M). CVKD YTD gains are higher at: 23.894 vs. AKTX (-7.439). CVKD has higher annual earnings (EBITDA): -14.36M vs. AKTX (-16.51M). CVKD has more cash in the bank: 3.86M vs. AKTX (2.48M). CVKD has less debt than AKTX: CVKD (0) vs AKTX (2.12M). AKTX (0) and CVKD (0) have equivalent revenues.
AKTXCVKDAKTX / CVKD
Capitalization9.8M19.6M50%
EBITDA-16.51M-14.36M115%
Gain YTD-7.43923.894-31%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.48M3.86M64%
Total Debt2.12M0-
FUNDAMENTALS RATINGS
AKTX: Fundamental Ratings
AKTX
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AKTXCVKD
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
74%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
AKTX
Daily Signal:
Gain/Loss:
CVKD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYCU2.600.07
+2.77%
Cycurion Inc.
CNP39.060.46
+1.19%
CenterPoint Energy
AHL37.27N/A
N/A
Aspen Insurance Holdings Ltd.
SENEB110.27N/A
N/A
Seneca Foods Corp
EMPG17.36N/A
N/A
Empro Group Inc

AKTX and

Correlation & Price change

A.I.dvisor tells us that AKTX and KPRX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTX and KPRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKTX
1D Price
Change %
AKTX100%
-4.16%
KPRX - AKTX
30%
Poorly correlated
+1.37%
QURE - AKTX
30%
Poorly correlated
+3.95%
DSGN - AKTX
24%
Poorly correlated
+2.40%
CVKD - AKTX
24%
Poorly correlated
-3.11%
MOLN - AKTX
23%
Poorly correlated
+1.94%
More

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and RADX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and RADX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-3.11%
RADX - CVKD
29%
Poorly correlated
+0.58%
GDTC - CVKD
29%
Poorly correlated
-23.35%
NEVPF - CVKD
27%
Poorly correlated
N/A
BEAM - CVKD
26%
Poorly correlated
+2.49%
ARDX - CVKD
25%
Poorly correlated
-2.13%
More